Quadrature Capital LTD Immunocore Holdings PLC Transaction History
Quadrature Capital LTD
- $5.81 Trillion
- Q2 2025
A detailed history of Quadrature Capital LTD transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Quadrature Capital LTD holds 14,975 shares of IMCR stock, worth $477,852. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,975Holding current value
$477,852% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IMCR
# of Institutions
148Shares Held
45MCall Options Held
297KPut Options Held
1.19M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.07MShares$226 Million0.14% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$155 Million2.35% of portfolio
-
Wellington Management Group LLP Boston, MA4.21MShares$134 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.77MShares$120 Million0.1% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.44MShares$77.9 Million1.74% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.4B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...